Letter to the Editor: Sodium‐Glucose Cotransporter‐2 Inhibitors Are Not the Magic Pills for Control of Ascites in Cirrhosis and Diabetes
Karan Kumar, Anand Kulkarni – 3 June 2020
Letter to the Editor: Sodium‐Glucose Cotransporter 2 Inhibitors Ameliorate Ascites and Peripheral Edema in Patients With Cirrhosis and Diabetes
Dimitrios Patoulias, Alexandra Katsimardou, Christodoulos Papadopoulos, Michael Doumas – 3 June 2020
Letter to the Editor: Cilofexor in Patients With Nonalcoholic Steatohepatitis (NASH): Is It Really Effective?
Ankur Jindal, Shiv K. Sarin – 2 June 2020
Severe Refractory Checkpoint Inhibitor‐Related Hepatitis Reversed With Anti‐Thymocyte Globulin and n‐Acetylcysteine
Douglas Motomura, Tara Baetz, Andrea Grin, Jennifer A. Flemming – 2 June 2020
Reply
Guadalupe García‐Tsao, Iaarah Montalvo‐Gordon – 2 June 2020
Renal Function Parameters and Serum Sodium Enhance Prediction of Wait‐List Outcomes in Pediatric Liver Transplantation
Leanne Thalji, Nassir M. Thalji, Julie K. Heimbach, Samar H. Ibrahim, Patrick S. Kamath, Andrew Hanson, Phillip J. Schulte, Dawit T. Haile, Daryl J. Kor – 2 June 2020
Biopsy Pathology and Immunohistochemistry of a Case of Immune‐Mediated Drug‐Induced Liver Injury With Atabecestat
Sandra De Jonghe, Daniel Weinstock, Jason Aligo, Kay Washington, Dean Naisbitt – 2 June 2020
Biopsy Pathology and Immunohistochemistry of a Case of Immune‐Mediated Drug‐Induced Liver Injury With Atabecestat
Sandra De Jonghe, Daniel Weinstock, Jason Aligo, Kay Washington, Dean Naisbitt – 2 June 2020
Reply
Sanjay Kumar Yadav, Narendr Singh Choudhary, Arvinder Singh Soin – 2 June 2020
Is Portal Inflow Modulation Always Necessary for Successful Utilization of Small Volume Living Donor Liver Grafts?
Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Sezai Yilmaz – 2 June 2020